Literature DB >> 14642282

Ubiquitination regulates PSD-95 degradation and AMPA receptor surface expression.

Marcie Colledge1, Eric M Snyder, Robert A Crozier, Jacquelyn A Soderling, Yetao Jin, Lorene K Langeberg, Hua Lu, Mark F Bear, John D Scott.   

Abstract

PSD-95 is a major scaffolding protein of the postsynaptic density, tethering NMDA- and AMPA-type glutamate receptors to signaling proteins and the neuronal cytoskeleton. Here we show that PSD-95 is regulated by the ubiquitin-proteasome pathway. PSD-95 interacts with and is ubiquitinated by the E3 ligase Mdm2. In response to NMDA receptor activation, PSD-95 is ubiquitinated and rapidly removed from synaptic sites by proteasome-dependent degradation. Mutations that block PSD-95 ubiquitination prevent NMDA-induced AMPA receptor endocytosis. Likewise, proteasome inhibitors prevent NMDA-induced AMPA receptor internalization and synaptically induced long-term depression. This is consistent with the notion that PSD-95 levels are an important determinant of AMPA receptor number at the synapse. These data suggest that ubiquitination of PSD-95 through an Mdm2-mediated pathway is critical in regulating AMPA receptor surface expression during synaptic plasticity.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14642282      PMCID: PMC3963808          DOI: 10.1016/s0896-6273(03)00687-1

Source DB:  PubMed          Journal:  Neuron        ISSN: 0896-6273            Impact factor:   17.173


  62 in total

Review 1.  The ARF/p53 pathway.

Authors:  C J Sherr; J D Weber
Journal:  Curr Opin Genet Dev       Date:  2000-02       Impact factor: 5.578

2.  Internalization of the Kv1.4 potassium channel is suppressed by clustering interactions with PSD-95.

Authors:  D G Jugloff; R Khanna; L C Schlichter; O T Jones
Journal:  J Biol Chem       Date:  2000-01-14       Impact factor: 5.157

3.  Targeting of PKA to glutamate receptors through a MAGUK-AKAP complex.

Authors:  M Colledge; R A Dean; G K Scott; L K Langeberg; R L Huganir; J D Scott
Journal:  Neuron       Date:  2000-07       Impact factor: 17.173

Review 4.  Ubiquitin-mediated proteolysis in learning and memory.

Authors:  D G Chain; J H Schwartz; A N Hegde
Journal:  Mol Neurobiol       Date:  1999 Oct-Dec       Impact factor: 5.590

5.  Multi-PDZ domain protein MUPP1 is a cellular target for both adenovirus E4-ORF1 and high-risk papillomavirus type 18 E6 oncoproteins.

Authors:  S S Lee; B Glaunsinger; F Mantovani; L Banks; R T Javier
Journal:  J Virol       Date:  2000-10       Impact factor: 5.103

6.  Regulation of AMPA receptor-mediated synaptic transmission by clathrin-dependent receptor internalization.

Authors:  H Y Man; J W Lin; W H Ju; G Ahmadian; L Liu; L E Becker; M Sheng; Y T Wang
Journal:  Neuron       Date:  2000-03       Impact factor: 17.173

7.  Control of GluR1 AMPA receptor function by cAMP-dependent protein kinase.

Authors:  T G Banke; D Bowie; H Lee; R L Huganir; A Schousboe; S F Traynelis
Journal:  J Neurosci       Date:  2000-01-01       Impact factor: 6.167

8.  Regulation of distinct AMPA receptor phosphorylation sites during bidirectional synaptic plasticity.

Authors:  H K Lee; M Barbarosie; K Kameyama; M F Bear; R L Huganir
Journal:  Nature       Date:  2000-06-22       Impact factor: 49.962

9.  Dynamin-dependent endocytosis of ionotropic glutamate receptors.

Authors:  R C Carroll; E C Beattie; H Xia; C Lüscher; Y Altschuler; R A Nicoll; R C Malenka; M von Zastrow
Journal:  Proc Natl Acad Sci U S A       Date:  1999-11-23       Impact factor: 11.205

10.  Oncogenic human papillomavirus E6 proteins target the discs large tumour suppressor for proteasome-mediated degradation.

Authors:  D Gardiol; C Kühne; B Glaunsinger; S S Lee; R Javier; L Banks
Journal:  Oncogene       Date:  1999-09-30       Impact factor: 9.867

View more
  253 in total

1.  Subtype selective NMDA receptor antagonists induce recovery of synapses lost following exposure to HIV-1 Tat.

Authors:  A H Shin; H J Kim; S A Thayer
Journal:  Br J Pharmacol       Date:  2012-06       Impact factor: 8.739

2.  Delayed stabilization of dendritic spines in fragile X mice.

Authors:  Alberto Cruz-Martín; Michelle Crespo; Carlos Portera-Cailliau
Journal:  J Neurosci       Date:  2010-06-09       Impact factor: 6.167

3.  The deubiquitinating enzyme USP-46 negatively regulates the degradation of glutamate receptors to control their abundance in the ventral nerve cord of Caenorhabditis elegans.

Authors:  Jennifer R Kowalski; Caroline L Dahlberg; Peter Juo
Journal:  J Neurosci       Date:  2011-01-26       Impact factor: 6.167

4.  Protein ubiquitination in postsynaptic densities after transient cerebral ischemia.

Authors:  Chen Li Liu; Maryann E Martone; Bingren R Hu
Journal:  J Cereb Blood Flow Metab       Date:  2004-11       Impact factor: 6.200

Review 5.  Protein homeostasis and synaptic plasticity.

Authors:  Iván J Cajigas; Tristan Will; Erin M Schuman
Journal:  EMBO J       Date:  2010-08-18       Impact factor: 11.598

Review 6.  The ubiquitin-proteasome pathway and synaptic plasticity.

Authors:  Ashok N Hegde
Journal:  Learn Mem       Date:  2010-06-21       Impact factor: 2.460

7.  APC(Cdh1) mediates EphA4-dependent downregulation of AMPA receptors in homeostatic plasticity.

Authors:  Amy K Y Fu; Kwok-Wang Hung; Wing-Yu Fu; Chong Shen; Yu Chen; Jun Xia; Kwok-On Lai; Nancy Y Ip
Journal:  Nat Neurosci       Date:  2010-12-26       Impact factor: 24.884

8.  A novel role for the immunoproteasome in retinal function.

Authors:  Stacy A Hussong; Heidi Roehrich; Rebecca J Kapphahn; Marcela Maldonado; Machelle T Pardue; Deborah A Ferrington
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-02-09       Impact factor: 4.799

9.  UCH-L1 inhibition involved in CREB dephosphorylation in hippocampal slices.

Authors:  Min Xie; Shao-Hui Wang; Zhi-Min Lu; Ying Pan; Qi-Cai Chen; Xiao-Mei Liao
Journal:  J Mol Neurosci       Date:  2013-12-10       Impact factor: 3.444

10.  NMDA receptor-dependent synaptic translocation of insulin receptor substrate p53 via protein kinase C signaling.

Authors:  Kei Hori; Hiroki Yasuda; Daijiro Konno; Hisato Maruoka; Tadaharu Tsumoto; Kenji Sobue
Journal:  J Neurosci       Date:  2005-03-09       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.